Enveric Biosciences, Inc. (ENVB)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Aug 28, 13:57
Enveric Biosciences EPS Diluted (TTM) : -16.46 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.46 |
| March 31, 2026 | -27.35 |
| December 31, 2025 | -27.48 |
| September 30, 2025 | -81.48 |
| June 30, 2025 | -70.90 |
| March 31, 2025 | -59.50 |
| December 31, 2024 | -58.90 |
| September 30, 2024 | -2.564 |
| June 30, 2024 | -3.628 |
| March 31, 2024 | -6.417 |
| December 31, 2023 | -8.113 |
| September 30, 2023 | -10.89 |
| June 30, 2023 | -11.04 |
| March 31, 2023 | -10.65 |
| December 31, 2022 | -13.68 |
| September 30, 2022 | -74.07 |
| June 30, 2022 | -78.47 |
| March 31, 2022 | -77.95 |
| December 31, 2021 | -82.63 |
| September 30, 2021 | -3490.21 |
| June 30, 2021 | -8678.79 |
| March 31, 2021 | -15671.10 |
| September 30, 2020 | -15870.12 |
| June 30, 2020 | -12404.02 |
| March 31, 2020 | -7344.03 |
| Date | Value |
|---|---|
| December 31, 2019 | -567.09 |
| September 30, 2019 | -3119.70 |
| June 30, 2019 | -2310.80 |
| March 31, 2019 | -2539.40 |
| December 31, 2018 | -2892.60 |
| September 30, 2018 | -580.95 |
| June 30, 2018 | -2933.75 |
| March 31, 2018 | -3870.70 |
| December 31, 2017 | -81330.00 |
| September 30, 2017 | -80411.70 |
| June 30, 2017 | -79511.70 |
| March 31, 2017 | -159211.7 |
| December 31, 2016 | -81681.70 |
| September 30, 2016 | -82900.00 |
| June 30, 2016 | -82350.00 |
| March 31, 2016 | -1300.00 |
| December 31, 2015 | -814.97 |
| September 30, 2015 | -125.72 |
| June 30, 2015 | -44.21 |
| March 31, 2015 | -162.01 |
| December 31, 2014 | -193.71 |
| September 30, 2014 | -38.74 |
| June 30, 2014 | -53.71 |
| March 31, 2014 | -14.09 |
| December 31, 2013 | -1.761 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| LENZ Therapeutics, Inc. | -4.081 |
| Impact BioMedical, Inc. | -0.0982 |
| ANI Pharmaceuticals, Inc. | 4.632 |
| Corcept Therapeutics, Inc. | 0.4187 |
| Veru, Inc. | -0.6109 |